Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Tsuji

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Diagnostic Microbiology and Infectious Disease|December 22, 2005
Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycinBrian T Tsuji, Michael J Rybak
Antimicrobial Agents and Chemotherapy|June 28, 2005
Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsBrian T Tsuji, Michael J Rybak
Pharmacotherapy|December 25, 2009
A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancinMichael T Guskey, Brian T Tsuji
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 21, 2018
Concentration-dependent plasma protein binding: Expect the unexpectedRoger L Nation, Ursula Theuretzbacher, Brian T Tsuji, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2009
Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotypeDamir Begic, Christof von Eiff, Brian T Tsuji
Pharmacotherapy|July 28, 2007
Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndromeMasashi Narita, Brian T Tsuji, Victor L Yu
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing use of quinolones in the critically illJenny C Yang, Brian T Tsuji, Alan Forrest
International Journal of Antimicrobial Agents|November 21, 2016
Synergistic combinations of polymyxinsJustin R Lenhard, Roger L Nation, Brian T Tsuji
Antimicrobial Agents and Chemotherapy|July 1, 2009
Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotypeMarina Wu, Christof von Eiff, Nahed Al Laham, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosaNeang S Ly, Jenny Yang, Jurgen B Bulitta, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Diagnostic Microbiology and Infectious Disease|December 22, 2005
Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycinBrian T Tsuji, Michael J Rybak
Antimicrobial Agents and Chemotherapy|June 28, 2005
Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsBrian T Tsuji, Michael J Rybak
Pharmacotherapy|December 25, 2009
A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancinMichael T Guskey, Brian T Tsuji
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 21, 2018
Concentration-dependent plasma protein binding: Expect the unexpectedRoger L Nation, Ursula Theuretzbacher, Brian T Tsuji, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2009
Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotypeDamir Begic, Christof von Eiff, Brian T Tsuji
Pharmacotherapy|July 28, 2007
Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndromeMasashi Narita, Brian T Tsuji, Victor L Yu
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing use of quinolones in the critically illJenny C Yang, Brian T Tsuji, Alan Forrest
International Journal of Antimicrobial Agents|November 21, 2016
Synergistic combinations of polymyxinsJustin R Lenhard, Roger L Nation, Brian T Tsuji
Antimicrobial Agents and Chemotherapy|July 1, 2009
Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotypeMarina Wu, Christof von Eiff, Nahed Al Laham, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosaNeang S Ly, Jenny Yang, Jurgen B Bulitta, et al.
Pageof 11